CFTR and nasopharyngeal carcinoma: Enhanced CFTR expression inhibits various cancerous processes such as EMT in breast carcinoma [89], lung cancer [90], NPC [87], endometrial carcinoma cells [91], prostate cancer [92], and intestinal carcinoma [93].